Aetna did not cover the service because it was considered “experimental/investigational” and “not identified as widely used and generally accepted for the proposed uses as reported in nationally recognized peer-reviewed medical literature,” according to a June 27 blog post from ASNC.
In the letter, the two medical groups urged the payer to reverse the policy because its policy was not aligned with current U.S. standards and practice of cardiac PET/CT scans.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
